Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil;Erstmanifestation einer diffusen proliferativen lupus-nephritis unter immunsuppressiver langzeittherapie mit mycophenolatmofetil

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 41, 2006, Pages 2266-2269

  Sixdorf, U ^a   Bauer, H ^a   Märker Hermann, Elizabeth ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

CNS involvement; Mycofenolate mofetil; Proliferative lupus nephritis; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ALTERNATIVE MEDICINE; ANAMNESIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; ADULT; BIOPSY; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MYCOPHENOLIC ACID; PLASMAPHERESIS; PULSE THERAPY, DRUG; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 33750681982     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-951361     Document Type: Article

References (17)

1. Ahmadi-Simab K, Lamprecht K, Gross WL. Progression of lupus nephritis during treatment with mycophenolate mofetil. Ann Rheum Dis 2004; 63: 1179-1180
2. Austin HA, Klippel JH, Balow JE, Le Riche NG, Steinberg AD, Plotz OH, Decker JL. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. New Engl J Med 1986; 314: 614-619
3. Balow JE, Austin HA. Maintenance Therapy for Lupus Nephritis - something old, something new. New Engl J Med 2004; 350: 1044-1046
4. Chan TM et al. Hong Kong-Guangzhou Nephrology Study Group. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. New Engl J Med 2000; 343: 1156-1162
5. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D. Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004; 350: 971-980
6. Dooley MA, Cosio FG, Nachman PH, Falkenhain ME, Hogan SL, Falk RJ, Hebert LA. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol 1999; 10: 833-839
7. Euler HH, Schroeder JO, Zeuner RA, Teske EA. A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: design of the LPSG trial. Int J Artif Organs 1991; 14: 639-646
8. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ. Treatment-free remission in severe systemic lupus erythematodes following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 1994; 37: 1784-1794
9. Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC. Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2004; 43: 197-208
10. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005; 353: 2219-2228
11. Isenberg DA. B cell targeted therapy in autoimmune diseases. J Rheumatol Suppl 2006; 77: 24-28
12. Karim MY, Alba P, Cuadrado MJ, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR. Mycophenolatmofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology 2002; 41: 876-882
13. Mok CC. Therapeutic options for resistant lupus nephritis. Semin Arthritis Rheum 2006; [Epub ahead of print]
14. Neuwelt CM. The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Ther Apher Dial 2003; 7: 173-182
15. Schwarting A, Märker-Hermann E. Renale Manifestationen rheumatischer Erkrankungen. Z Rheumatol 2005; 64: 18-25
16. Warrens AN. The evolving role of mycophenolate mofetil in renal transplantation. Q J Med 2000; 93: 15-20
17. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530